United States Bulk Drug Market Report 2017

October 2017 | 121 pages | ID: U0671F638E6EN
QYResearch

Abstracts

In this report, the United States Bulk Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Bulk Drug in these regions, from 2012 to 2022 (forecast).

United States Bulk Drug market competition by top manufacturers/players, with Bulk Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva
• Novartis
• Pfizer
• Johnson & Johnson
• Mylan
• North China Pharmaceutical Group
• Dr. Reddy’s Laboratories
• Roche
• Aurobindo pharma
• Sun Pharmaceutical Industries
• Boehringer Ingelheim GmbH
• Bayer
• BASF
• DSM
• Zhejiang Medicine
• Biocon
• Johnson Matthey
• Hisun Pharmacy
• Cambrex
• Shandong Xinhua Pharmaceutical
• Lonza group
• Huahai Pharmaceutical
• Haerbin Pharmaceutical Group

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Vitamin
• Antibiotic
• Iohexol
• Hormone
• Amino Acid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Bulk Drug for each application, including

• Orthopedics Disease
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Bulk Drug Market Report 2017

1 BULK DRUG OVERVIEW

1.1 Product Overview and Scope of Bulk Drug
1.2 Classification of Bulk Drug by Product Category
  1.2.1 United States Bulk Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Bulk Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Vitamin
  1.2.4 Antibiotic
  1.2.5 Iohexol
  1.2.6 Hormone
  1.2.7 Amino Acid
1.3 United States Bulk Drug Market by Application/End Users
  1.3.1 United States Bulk Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Orthopedics Disease
  1.3.3 Others
1.4 United States Bulk Drug Market by Region
  1.4.1 United States Bulk Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Bulk Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Bulk Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Bulk Drug Status and Prospect (2012-2022)
  1.4.5 New England Bulk Drug Status and Prospect (2012-2022)
  1.4.6 The South Bulk Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Bulk Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Bulk Drug (2012-2022)
  1.5.1 United States Bulk Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Bulk Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES BULK DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Bulk Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Bulk Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Bulk Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Bulk Drug Market Competitive Situation and Trends
  2.4.1 United States Bulk Drug Market Concentration Rate
  2.4.2 United States Bulk Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Bulk Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BULK DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Bulk Drug Sales and Market Share by Region (2012-2017)
3.2 United States Bulk Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Bulk Drug Price by Region (2012-2017)

4 UNITED STATES BULK DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Bulk Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Bulk Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Bulk Drug Price by Type (2012-2017)
4.4 United States Bulk Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BULK DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Bulk Drug Sales and Market Share by Application (2012-2017)
5.2 United States Bulk Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BULK DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Teva
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Bulk Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Bulk Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Bulk Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Bulk Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.2 Bulk Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 North China Pharmaceutical Group
  6.6.2 Bulk Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 North China Pharmaceutical Group Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Dr. Reddy’s Laboratories
  6.7.2 Bulk Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Dr. Reddy’s Laboratories Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Roche
  6.8.2 Bulk Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Roche Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Aurobindo pharma
  6.9.2 Bulk Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Aurobindo pharma Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sun Pharmaceutical Industries
  6.10.2 Bulk Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sun Pharmaceutical Industries Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim GmbH
6.12 Bayer
6.13 BASF
6.14 DSM
6.15 Zhejiang Medicine
6.16 Biocon
6.17 Johnson Matthey
6.18 Hisun Pharmacy
6.19 Cambrex
6.20 Shandong Xinhua Pharmaceutical
6.21 Lonza group
6.22 Huahai Pharmaceutical
6.23 Haerbin Pharmaceutical Group

7 BULK DRUG MANUFACTURING COST ANALYSIS

7.1 Bulk Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bulk Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Bulk Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bulk Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BULK DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Bulk Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Bulk Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Bulk Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Bulk Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Bulk Drug
Figure United States Bulk Drug Market Size (K MT) by Type (2012-2022)
Figure United States Bulk Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Vitamin Product Picture
Figure Antibiotic Product Picture
Figure Iohexol Product Picture
Figure Hormone Product Picture
Figure Amino Acid Product Picture
Figure United States Bulk Drug Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Bulk Drug by Application in 2016
Figure Orthopedics Disease Examples
Table Key Downstream Customer in Orthopedics Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Bulk Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Bulk Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Bulk Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Bulk Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Bulk Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Bulk Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Bulk Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bulk Drug Sales (K MT) and Growth Rate (2012-2022)
Figure United States Bulk Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bulk Drug Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Bulk Drug Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Bulk Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bulk Drug Sales Share by Players/Suppliers
Figure 2017 United States Bulk Drug Sales Share by Players/Suppliers
Figure United States Bulk Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Bulk Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Bulk Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bulk Drug Revenue Share by Players/Suppliers
Figure 2017 United States Bulk Drug Revenue Share by Players/Suppliers
Table United States Market Bulk Drug Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Bulk Drug Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Bulk Drug Market Share of Top 3 Players/Suppliers
Figure United States Bulk Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Bulk Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Bulk Drug Product Category
Table United States Bulk Drug Sales (K MT) by Region (2012-2017)
Table United States Bulk Drug Sales Share by Region (2012-2017)
Figure United States Bulk Drug Sales Share by Region (2012-2017)
Figure United States Bulk Drug Sales Market Share by Region in 2016
Table United States Bulk Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Bulk Drug Revenue Share by Region (2012-2017)
Figure United States Bulk Drug Revenue Market Share by Region (2012-2017)
Figure United States Bulk Drug Revenue Market Share by Region in 2016
Table United States Bulk Drug Price (USD/MT) by Region (2012-2017)
Table United States Bulk Drug Sales (K MT) by Type (2012-2017)
Table United States Bulk Drug Sales Share by Type (2012-2017)
Figure United States Bulk Drug Sales Share by Type (2012-2017)
Figure United States Bulk Drug Sales Market Share by Type in 2016
Table United States Bulk Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Bulk Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bulk Drug by Type (2012-2017)
Figure Revenue Market Share of Bulk Drug by Type in 2016
Table United States Bulk Drug Price (USD/MT) by Types (2012-2017)
Figure United States Bulk Drug Sales Growth Rate by Type (2012-2017)
Table United States Bulk Drug Sales (K MT) by Application (2012-2017)
Table United States Bulk Drug Sales Market Share by Application (2012-2017)
Figure United States Bulk Drug Sales Market Share by Application (2012-2017)
Figure United States Bulk Drug Sales Market Share by Application in 2016
Table United States Bulk Drug Sales Growth Rate by Application (2012-2017)
Figure United States Bulk Drug Sales Growth Rate by Application (2012-2017)
Table Teva Basic Information List
Table Teva Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Bulk Drug Sales Growth Rate (2012-2017)
Figure Teva Bulk Drug Sales Market Share in United States (2012-2017)
Figure Teva Bulk Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Bulk Drug Sales Growth Rate (2012-2017)
Figure Novartis Bulk Drug Sales Market Share in United States (2012-2017)
Figure Novartis Bulk Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Bulk Drug Sales Growth Rate (2012-2017)
Figure Pfizer Bulk Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Bulk Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Bulk Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Bulk Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Bulk Drug Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Bulk Drug Sales Growth Rate (2012-2017)
Figure Mylan Bulk Drug Sales Market Share in United States (2012-2017)
Figure Mylan Bulk Drug Revenue Market Share in United States (2012-2017)
Table North China Pharmaceutical Group Basic Information List
Table North China Pharmaceutical Group Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure North China Pharmaceutical Group Bulk Drug Sales Growth Rate (2012-2017)
Figure North China Pharmaceutical Group Bulk Drug Sales Market Share in United States (2012-2017)
Figure North China Pharmaceutical Group Bulk Drug Revenue Market Share in United States (2012-2017)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Bulk Drug Sales Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Bulk Drug Sales Market Share in United States (2012-2017)
Figure Dr. Reddy’s Laboratories Bulk Drug Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Bulk Drug Sales Growth Rate (2012-2017)
Figure Roche Bulk Drug Sales Market Share in United States (2012-2017)
Figure Roche Bulk Drug Revenue Market Share in United States (2012-2017)
Table Aurobindo pharma Basic Information List
Table Aurobindo pharma Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aurobindo pharma Bulk Drug Sales Growth Rate (2012-2017)
Figure Aurobindo pharma Bulk Drug Sales Market Share in United States (2012-2017)
Figure Aurobindo pharma Bulk Drug Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Bulk Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Bulk Drug Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Bulk Drug Sales Market Share in United States (2012-2017)
Figure Sun Pharmaceutical Industries Bulk Drug Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Bayer Basic Information List
Table BASF Basic Information List
Table DSM Basic Information List
Table Zhejiang Medicine Basic Information List
Table Biocon Basic Information List
Table Johnson Matthey Basic Information List
Table Hisun Pharmacy Basic Information List
Table Cambrex Basic Information List
Table Shandong Xinhua Pharmaceutical Basic Information List
Table Lonza group Basic Information List
Table Huahai Pharmaceutical Basic Information List
Table Haerbin Pharmaceutical Group Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bulk Drug
Figure Manufacturing Process Analysis of Bulk Drug
Figure Bulk Drug Industrial Chain Analysis
Table Raw Materials Sources of Bulk Drug Major Players/Suppliers in 2016
Table Major Buyers of Bulk Drug
Table Distributors/Traders List
Figure United States Bulk Drug Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Bulk Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Bulk Drug Price (USD/MT) Trend Forecast (2017-2022)
Table United States Bulk Drug Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Bulk Drug Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Bulk Drug Sales Volume (K MT) Forecast by Type in 2022
Table United States Bulk Drug Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Bulk Drug Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Bulk Drug Sales Volume (K MT) Forecast by Application in 2022
Table United States Bulk Drug Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Bulk Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bulk Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bulk Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources